Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 14 | 2024 | 1848 | 3.560 |
Why?
|
Postmenopause | 8 | 2023 | 2493 | 1.990 |
Why?
|
Sleep | 19 | 2023 | 4712 | 1.940 |
Why?
|
Ovarian Neoplasms | 10 | 2021 | 4808 | 1.400 |
Why?
|
Ovulation | 2 | 2020 | 180 | 1.360 |
Why?
|
Neoplasms, Glandular and Epithelial | 4 | 2016 | 484 | 1.240 |
Why?
|
Circadian Rhythm | 6 | 2023 | 2563 | 1.220 |
Why?
|
Adiposity | 5 | 2019 | 1844 | 1.130 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2024 | 12154 | 1.050 |
Why?
|
Hyperglycemia | 3 | 2022 | 1373 | 0.990 |
Why?
|
Parity | 2 | 2019 | 921 | 0.980 |
Why?
|
Atherosclerosis | 9 | 2023 | 3502 | 0.960 |
Why?
|
Spinal Fractures | 2 | 2022 | 694 | 0.950 |
Why?
|
Actigraphy | 6 | 2023 | 514 | 0.930 |
Why?
|
Premenopause | 2 | 2020 | 1034 | 0.910 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2021 | 1064 | 0.870 |
Why?
|
C-Reactive Protein | 4 | 2024 | 3805 | 0.860 |
Why?
|
Hip Fractures | 2 | 2022 | 982 | 0.850 |
Why?
|
Receptors, Leptin | 4 | 2019 | 350 | 0.810 |
Why?
|
Disorders of Excessive Somnolence | 2 | 2023 | 276 | 0.790 |
Why?
|
Ovarian Function Tests | 1 | 2020 | 11 | 0.740 |
Why?
|
Nurses | 5 | 2023 | 2458 | 0.730 |
Why?
|
Dehydroepiandrosterone | 2 | 2019 | 257 | 0.700 |
Why?
|
Phthalic Acids | 5 | 2016 | 474 | 0.680 |
Why?
|
Prospective Studies | 31 | 2023 | 53833 | 0.670 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2037 | 0.660 |
Why?
|
Risk Factors | 36 | 2024 | 73418 | 0.610 |
Why?
|
Diet, Vegetarian | 1 | 2019 | 183 | 0.580 |
Why?
|
Menopause | 4 | 2023 | 1639 | 0.570 |
Why?
|
Body Mass Index | 14 | 2022 | 12794 | 0.570 |
Why?
|
Contraceptives, Oral | 1 | 2019 | 554 | 0.570 |
Why?
|
Adipokines | 2 | 2016 | 311 | 0.570 |
Why?
|
Cardiovascular Diseases | 11 | 2023 | 15619 | 0.520 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2016 | 211 | 0.510 |
Why?
|
Cross-Sectional Studies | 19 | 2023 | 25540 | 0.500 |
Why?
|
Amino Acids | 2 | 2022 | 1714 | 0.500 |
Why?
|
Obesity | 8 | 2023 | 12802 | 0.500 |
Why?
|
Ovary | 1 | 2019 | 959 | 0.500 |
Why?
|
Diet | 5 | 2022 | 7950 | 0.490 |
Why?
|
Female | 64 | 2024 | 386339 | 0.480 |
Why?
|
Self Report | 4 | 2023 | 3649 | 0.470 |
Why?
|
Follow-Up Studies | 15 | 2022 | 39089 | 0.460 |
Why?
|
Middle Aged | 45 | 2024 | 217250 | 0.460 |
Why?
|
Depression | 7 | 2022 | 7920 | 0.450 |
Why?
|
Pregnancy in Diabetics | 1 | 2014 | 191 | 0.430 |
Why?
|
Child Abuse | 1 | 2022 | 1058 | 0.430 |
Why?
|
Hydrocortisone | 2 | 2019 | 1795 | 0.430 |
Why?
|
Environmental Pollutants | 4 | 2016 | 1241 | 0.430 |
Why?
|
Pregnancy Complications | 3 | 2017 | 2918 | 0.430 |
Why?
|
Blood Glucose | 6 | 2022 | 6332 | 0.420 |
Why?
|
Longevity | 1 | 2020 | 1034 | 0.420 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 373 | 0.420 |
Why?
|
Metabolic Diseases | 1 | 2019 | 685 | 0.410 |
Why?
|
Postpartum Period | 3 | 2017 | 1160 | 0.410 |
Why?
|
Humans | 81 | 2024 | 752810 | 0.410 |
Why?
|
Leptin | 5 | 2023 | 1593 | 0.400 |
Why?
|
Coronary Disease | 4 | 2022 | 5996 | 0.400 |
Why?
|
Hypertension | 4 | 2021 | 8497 | 0.400 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1871 | 0.390 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 383 | 0.380 |
Why?
|
Inflammation | 6 | 2023 | 10692 | 0.380 |
Why?
|
Adult | 37 | 2024 | 217168 | 0.370 |
Why?
|
Adiponectin | 5 | 2023 | 1111 | 0.360 |
Why?
|
Endocrine Disruptors | 1 | 2014 | 262 | 0.360 |
Why?
|
Insulin | 7 | 2022 | 6566 | 0.340 |
Why?
|
Sex Factors | 3 | 2019 | 10454 | 0.340 |
Why?
|
Incidence | 8 | 2022 | 21162 | 0.330 |
Why?
|
Stress, Psychological | 3 | 2024 | 4338 | 0.320 |
Why?
|
Insulin Resistance | 1 | 2022 | 3910 | 0.320 |
Why?
|
Metabolomics | 3 | 2024 | 1602 | 0.310 |
Why?
|
Aged | 27 | 2024 | 166705 | 0.300 |
Why?
|
Sleep Deprivation | 4 | 2023 | 833 | 0.300 |
Why?
|
Life Style | 5 | 2023 | 3858 | 0.300 |
Why?
|
Adipose Tissue | 2 | 2016 | 3285 | 0.290 |
Why?
|
Age Factors | 3 | 2020 | 18302 | 0.290 |
Why?
|
Time Factors | 8 | 2021 | 39885 | 0.280 |
Why?
|
Saliva | 3 | 2019 | 801 | 0.260 |
Why?
|
United States | 16 | 2024 | 71434 | 0.250 |
Why?
|
Motor Activity | 1 | 2015 | 2683 | 0.250 |
Why?
|
Health Surveys | 4 | 2020 | 4014 | 0.250 |
Why?
|
Polysomnography | 5 | 2023 | 1807 | 0.240 |
Why?
|
Overweight | 2 | 2017 | 2400 | 0.240 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2019 | 694 | 0.240 |
Why?
|
Feeding Behavior | 1 | 2016 | 3173 | 0.230 |
Why?
|
Noise, Transportation | 1 | 2023 | 51 | 0.210 |
Why?
|
Longitudinal Studies | 6 | 2022 | 14323 | 0.200 |
Why?
|
Aging | 2 | 2021 | 8573 | 0.200 |
Why?
|
Fasting | 2 | 2019 | 1591 | 0.190 |
Why?
|
Lipids | 3 | 2022 | 3325 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8420 | 0.180 |
Why?
|
Snoring | 1 | 2022 | 206 | 0.180 |
Why?
|
Ownership | 1 | 2022 | 331 | 0.180 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3375 | 0.170 |
Why?
|
C-Peptide | 2 | 2018 | 432 | 0.170 |
Why?
|
Comorbidity | 3 | 2020 | 10475 | 0.170 |
Why?
|
Basal Metabolism | 1 | 2020 | 162 | 0.160 |
Why?
|
Proportional Hazards Models | 4 | 2018 | 12455 | 0.160 |
Why?
|
Prevalence | 4 | 2019 | 15505 | 0.160 |
Why?
|
Calcium Channel Blockers | 1 | 2021 | 690 | 0.150 |
Why?
|
Interleukin-6 | 2 | 2019 | 3196 | 0.150 |
Why?
|
Diabetes Mellitus | 3 | 2024 | 5840 | 0.150 |
Why?
|
Nails | 1 | 2019 | 292 | 0.140 |
Why?
|
Health Occupations | 1 | 2018 | 221 | 0.140 |
Why?
|
Prolactin | 1 | 2018 | 630 | 0.140 |
Why?
|
Maternal Age | 1 | 2019 | 800 | 0.140 |
Why?
|
Odds Ratio | 3 | 2019 | 9701 | 0.140 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 765 | 0.130 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 281 | 0.130 |
Why?
|
Hyperhomocysteinemia | 1 | 2016 | 118 | 0.130 |
Why?
|
Ovariectomy | 1 | 2018 | 610 | 0.130 |
Why?
|
Gastroesophageal Reflux | 1 | 2023 | 813 | 0.130 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2021 | 1246 | 0.130 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 977 | 0.130 |
Why?
|
Hair | 1 | 2019 | 489 | 0.130 |
Why?
|
Nutrition Surveys | 4 | 2017 | 1699 | 0.130 |
Why?
|
Sleep, REM | 1 | 2019 | 592 | 0.130 |
Why?
|
Male | 17 | 2022 | 355160 | 0.120 |
Why?
|
Pregnancy Trimesters | 1 | 2016 | 196 | 0.120 |
Why?
|
Risk | 3 | 2017 | 9613 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1515 | 0.120 |
Why?
|
Flavones | 1 | 2014 | 67 | 0.120 |
Why?
|
Flavanones | 1 | 2014 | 72 | 0.120 |
Why?
|
Anthocyanins | 1 | 2014 | 79 | 0.120 |
Why?
|
Flavonols | 1 | 2014 | 84 | 0.120 |
Why?
|
Case-Control Studies | 2 | 2024 | 21857 | 0.120 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 545 | 0.120 |
Why?
|
Politics | 1 | 2020 | 795 | 0.110 |
Why?
|
Spine | 1 | 2020 | 1088 | 0.110 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2022 | 4470 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1341 | 0.110 |
Why?
|
Insulin Infusion Systems | 1 | 2014 | 212 | 0.110 |
Why?
|
Mexican Americans | 1 | 2014 | 163 | 0.110 |
Why?
|
Folic Acid | 2 | 2016 | 1300 | 0.110 |
Why?
|
Feces | 1 | 2019 | 1440 | 0.110 |
Why?
|
Exercise | 2 | 2022 | 5745 | 0.100 |
Why?
|
Adolescent | 6 | 2022 | 86822 | 0.100 |
Why?
|
Hysterectomy | 1 | 2018 | 896 | 0.100 |
Why?
|
Environmental Exposure | 3 | 2023 | 4342 | 0.100 |
Why?
|
Glucose Intolerance | 1 | 2016 | 578 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2019 | 2683 | 0.100 |
Why?
|
Pregnancy | 5 | 2017 | 29427 | 0.100 |
Why?
|
Pregnancy Trimester, First | 1 | 2016 | 902 | 0.100 |
Why?
|
Glucose Tolerance Test | 1 | 2015 | 1168 | 0.100 |
Why?
|
Neoplasms | 1 | 2021 | 21810 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5858 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2018 | 1208 | 0.100 |
Why?
|
Physical Fitness | 1 | 2016 | 726 | 0.100 |
Why?
|
Stroke | 3 | 2023 | 9887 | 0.100 |
Why?
|
Flavonoids | 1 | 2014 | 444 | 0.090 |
Why?
|
Body Weight | 2 | 2019 | 4605 | 0.090 |
Why?
|
Sleep Apnea Syndromes | 1 | 2019 | 971 | 0.090 |
Why?
|
Environmental Monitoring | 2 | 2014 | 1421 | 0.090 |
Why?
|
Wakefulness | 1 | 2017 | 1249 | 0.090 |
Why?
|
Hypercholesterolemia | 1 | 2017 | 1155 | 0.090 |
Why?
|
Diet, Mediterranean | 1 | 2016 | 725 | 0.090 |
Why?
|
Brain | 1 | 2016 | 26820 | 0.080 |
Why?
|
Retrospective Studies | 4 | 2022 | 79160 | 0.080 |
Why?
|
Young Adult | 8 | 2022 | 57732 | 0.080 |
Why?
|
Reference Values | 1 | 2016 | 4903 | 0.080 |
Why?
|
Anxiety | 2 | 2022 | 4456 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2241 | 0.080 |
Why?
|
Boston | 3 | 2016 | 9235 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12138 | 0.080 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2023 | 545 | 0.070 |
Why?
|
Child | 4 | 2022 | 78996 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2407 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17650 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2022 | 19907 | 0.070 |
Why?
|
Diabetes, Gestational | 1 | 2016 | 1227 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 29369 | 0.070 |
Why?
|
Weight Gain | 1 | 2016 | 2329 | 0.070 |
Why?
|
Logistic Models | 3 | 2016 | 13277 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2821 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2598 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4630 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2023 | 1815 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8363 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58347 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2015 | 2871 | 0.060 |
Why?
|
Weight Loss | 1 | 2014 | 2649 | 0.050 |
Why?
|
Research Design | 1 | 2019 | 6118 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2022 | 101 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6591 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11829 | 0.050 |
Why?
|
Aircraft | 1 | 2023 | 123 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3108 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2022 | 193 | 0.050 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 305 | 0.050 |
Why?
|
Blood Pressure | 1 | 2016 | 8468 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 565 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 41656 | 0.040 |
Why?
|
Tomography | 1 | 2021 | 408 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2023 | 703 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13403 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 872 | 0.040 |
Why?
|
Horses | 1 | 2019 | 295 | 0.040 |
Why?
|
Work Schedule Tolerance | 1 | 2022 | 550 | 0.040 |
Why?
|
Health Status | 2 | 2023 | 4050 | 0.040 |
Why?
|
Beverages | 1 | 2023 | 816 | 0.040 |
Why?
|
Hemoglobins | 1 | 2022 | 1510 | 0.030 |
Why?
|
Diethylhexyl Phthalate | 1 | 2016 | 82 | 0.030 |
Why?
|
Estradiol | 1 | 2023 | 1938 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2019 | 721 | 0.030 |
Why?
|
Metabolome | 1 | 2023 | 969 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15438 | 0.030 |
Why?
|
Meat | 1 | 2019 | 584 | 0.030 |
Why?
|
Immunoassay | 1 | 2018 | 745 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 415 | 0.030 |
Why?
|
Leisure Activities | 1 | 2016 | 305 | 0.030 |
Why?
|
Animals | 3 | 2022 | 166825 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23785 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2016 | 734 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23235 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2017 | 452 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 12451 | 0.030 |
Why?
|
Tea | 1 | 2014 | 283 | 0.030 |
Why?
|
Testosterone | 1 | 2023 | 2447 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1537 | 0.030 |
Why?
|
Mothers | 1 | 2022 | 2174 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3467 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2687 | 0.020 |
Why?
|
Emotions | 1 | 2023 | 2700 | 0.020 |
Why?
|
Pregnant Women | 1 | 2016 | 557 | 0.020 |
Why?
|
Prenatal Care | 1 | 2017 | 1104 | 0.020 |
Why?
|
China | 1 | 2016 | 2335 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5702 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2498 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2016 | 1913 | 0.020 |
Why?
|
Maternal Exposure | 1 | 2016 | 1029 | 0.020 |
Why?
|
Triglycerides | 1 | 2016 | 2469 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6363 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6245 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 6985 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40996 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8706 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2016 | 3369 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8499 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9899 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10200 | 0.010 |
Why?
|
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(97)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_